INS and chronic obstructive pulmonary disease: The progressive upregulation of SPP1 in COPD [55, 56] and its role as an upstream regulator in T2DM patients align with our findings [57], suggesting SPP1's involvement in apoptosis, insulin resistance, and islet function regulation—pivotal pathways in the evolution of both diseases [55, 58].